The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromacine.
The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine.

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromacine.
The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine.

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromacine.
The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine.

Epilepsy drugs used by millions of people may increase the risk of suicidal thoughts or behavior, the Food and Drug Administration warned Thursday in an alert to doctors.

Here's a round up of some recent news stories on nutrition, health, wellness, exercise and all the rest. There's a lot out there! -

Cavaliers wrestle with weight control
UV Cavalier Daily - The challenge of losing and gaining weight has faced much scrutiny in the recent past as the NCAA passed regulations banning unsafe forms of weight loss. Throughout the history of wrestling, meeting the challenge of packing the most muscle into a

FDA Approves Over The Counter Weight Loss Pills
Medical News Today - The American Food and Drug Administration (FDA) has approved Orlistat for use as an over the counter weight loss drug for adults who are overweight. The drug, which was originally approved for prescription in 1999, will retain prescription status at

Glaxo Reports Weak Rise in 4Q Profits
Forbes - Food and Drug Administration for its over-the-counter weight loss drug Alli. Alli, known clinically as Orlistat, is a lower-dose version of Xenical, a prescription weight loss medicine sold by Swiss drugmaker Roche Holdings AG. It will be the first FDA

Teacher's Weight Loss Motivates Students To Follow Suit
NewsNet 5 - CLEVELAND — We've all heard it a million times: It's better for your heart if you exercise and watch what you eat. That message doesn't always get through the way it should. But one Cleveland middle school teacher is changing the way her students

1st over-counter diet pill approved
Boston Online - WASHINGTON — The Food and Drug Administration yesterday approved the first diet pill for sale without a prescription in a marketplace dominated by unregulated over-the-counter supplements that promise weight loss. GlaxoSmithKline Consumer Healthcare

GSK's Obesity Drug OK'D for OTC Sales
INS News - GlaxoSmithKline said Thursday its weight-loss drug orlistat — to be marketed as Alli — has been OK'd for U.S. non-prescription sales. The company said the approval of orlistat, 60-mg capsules for over-the-counter sales marks the first time a

Shaping America's Health Comments on FDA Approval of Over-The-Counter
Forbes - Today the U.S. Food and Drug Administration (FDA) granted approval for the first over-the-counter weight loss medication. "While Shaping America's Health recognizes this development as an important strategy in combating issues associated with obesity

Choice raises concerns over weight loss drug dispensing
Australian Broadcasting Corp. - The consumers' association Choice is raising the alarm about a popular weight loss drug being inappropriately dispensed. Choice magazine sent a secret shopper who was not overweight to 30 Sydney pharmacies. In 24 cases, she was sold the weight loss

GlaxoSmithKline Weight-Loss OTC Drug Gets Go-Ahead
INS News - Feb. 8–GlaxoSmithKline's Moon-based North American Consumer Healthcare Division gained government approval yesterday to sell weight loss drug orlistat over the counter. The drug, to be marketed under the brand name Alli and slated to be available at

Reliv International Introduces Slimplicity(TM), a Unique New Weight
Hola Arkansas - The Reliv Slimplicity starter kit includes a month s supply of both the meal replacement product and the Accelerator capsules, a pedometer, a shaker cup for the meal replacement shake a No Cheat Sheet daily journal to keep track of progress. Reliv

FDA Approves Over-The-Counter Weight Loss Pill
All Headline News - Washington, D.C. (AHN) - In a first likely to shake up a diet industry bloated with bogus or unproven products; the Food and Drug Administration has approved over-the-counter sales of a weight loss drug. The drug, orlistat, will be the first

Comtamination of the food supply by terrorism remains a concern, and accidental contamination is a problem too. Many can imagine the panic associated with an accident that gets reported as a "suspicious act." So anyway, the FDA, doing what they can, has released new guidelines to help reduce the chances of accidential comtamination.

FDA Issues Guidance to Help Prevent Inadvertent Introduction of Allergens or Toxins into the Food and Feed Supply

The U.S. Food and Drug Administration (FDA) today issued guidance to industry to help prevent the inadvertent introduction of allergens or toxins into the United States food and feed supply. The guidance provides greater transparency by explaining how the agency will conduct its early safety evaluation of new proteins in new plant varieties, including bioengineered varieties, that are in development for possible use as food for humans or animals. This guidance is focused on resolving any potential food safety issues prior to possible inadvertent introduction of material from a new plant variety for which FDA has not been consulted.

FDA has not found, and does not believe, that new plant varieties under development for food and feed use generally pose any safety or regulatory concerns. The new guidance is consistent with FDA's policy of encouraging communication early in the development process for a new plant variety.

FDA believes that, given the low levels at which material from new plant varieties under development could possibly enter the food supply, any resulting food or feed safety concern would involve the potential that a new protein could in some people cause an allergic reaction, or be a toxin in people or animals. To prevent such a remote possibility, this guidance describes the procedure for early food safety evaluation of new proteins in plant varieties prior to the stage of development where the new proteins might inadvertently enter the food supply.

Under the guidance, entitled "Guidance for Industry: Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use," developers would voluntarily provide FDA with information about the food safety of new proteins at a relatively early stage of development of the new crops. Following a decision to commercialize a particular crop, it is recommended that each developer participate in FDA's voluntary premarket consultation procedures. To date, all new biotechnology-developed plant varieties intended to be used for food and feed in the United States have completed these consultation procedures before they entered the market.

The issuance of this guidance was proposed in August 2002 by the White House's Office of Science and Technology Policy as part of a series of federal actions involving also the Environmental Protection Agency and the United States Department of Agriculture. The purpose of these actions is to update field test requirements, and establish early voluntary food safety evaluations for new proteins produced by bioengineered plants.

FDA published a draft guidance document for comment on November 24, 2004. Today's final guidance includes several clarifications suggested in the comments received in response to the draft guidance document.

The full text of the guidance can be found online at: http://www.cfsan.fda.gov/~dms/guidance.html.

"Let thy Food be thy Medicine and thy Medicine be thy Food" — Hippocrates. That is the message from the founding father of modern medicine echoed in the controversial new documentary film Food Matters from Producer-Directors James Colquhoun and Laurentine ten Bosch. (PRWeb Mar 15, 2008)

Read the full story at http://www.prweb.com/releases/2008/03/prweb773104.htm